JPWO2022203044A1 - - Google Patents

Info

Publication number
JPWO2022203044A1
JPWO2022203044A1 JP2023509329A JP2023509329A JPWO2022203044A1 JP WO2022203044 A1 JPWO2022203044 A1 JP WO2022203044A1 JP 2023509329 A JP2023509329 A JP 2023509329A JP 2023509329 A JP2023509329 A JP 2023509329A JP WO2022203044 A1 JPWO2022203044 A1 JP WO2022203044A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023509329A
Other languages
Japanese (ja)
Other versions
JP7612001B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022203044A1 publication Critical patent/JPWO2022203044A1/ja
Application granted granted Critical
Publication of JP7612001B2 publication Critical patent/JP7612001B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22Testing for sterility conditions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D65/00Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
    • B01D65/10Testing of membranes or membrane apparatus; Detecting or repairing leaks
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D69/00Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/02Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/33Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/02Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance
    • G01N27/04Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance by investigating resistance
    • G01N27/06Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance by investigating resistance of a liquid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14321Viruses as such, e.g. new isolates, mutants or their genomic sequences

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Electrochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2023509329A 2021-03-26 2022-03-25 ウイルスクリアランス試験の方法 Active JP7612001B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021053527 2021-03-26
JP2021053527 2021-03-26
PCT/JP2022/014401 WO2022203044A1 (ja) 2021-03-26 2022-03-25 ウイルスクリアランス試験の方法

Publications (2)

Publication Number Publication Date
JPWO2022203044A1 true JPWO2022203044A1 (https=) 2022-09-29
JP7612001B2 JP7612001B2 (ja) 2025-01-10

Family

ID=83397485

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023509329A Active JP7612001B2 (ja) 2021-03-26 2022-03-25 ウイルスクリアランス試験の方法

Country Status (4)

Country Link
US (1) US20240175098A1 (https=)
EP (1) EP4317460B1 (https=)
JP (1) JP7612001B2 (https=)
WO (1) WO2022203044A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018075716A1 (en) * 2016-10-21 2018-04-26 Bayer Healthcare Llc Validation of continuous viral clearance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1195577C (zh) 1999-08-20 2005-04-06 旭化成制药株式会社 生理活性物质溶液用过滤膜
US9644187B2 (en) 2010-04-14 2017-05-09 Emd Millipore Corporation Methods of producing high titer, high purity virus stocks and methods of use thereof
KR101624089B1 (ko) 2012-11-22 2016-05-24 아사히 가세이 메디컬 가부시키가이샤 고감염가의 파보바이러스의 생산 방법
CA3197305A1 (en) * 2020-10-02 2022-04-07 Regeneron Pharmaceuticals, Inc. Continuous virus retentive filtration

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018075716A1 (en) * 2016-10-21 2018-04-26 Bayer Healthcare Llc Validation of continuous viral clearance

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BIOTECHNOL. BIOENG., vol. 114, no. 1, JPN6024030701, January 2017 (2017-01-01), pages 21 - 32, ISSN: 0005383849 *
BIOTECHNOL. PROGRESS, vol. 37, JPN6024030702, 5 October 2020 (2020-10-05), pages 3088 - 1, ISSN: 0005383850 *
MATEC WEB OF CONFERENCES, vol. 268, JPN6024030700, 2019, pages 01003, ISSN: 0005383848 *
PHARMACEUTICAL TECHNOLOGY, JPN6024030699, January 2019 (2019-01-01), pages 38 - 40, ISSN: 0005383847 *

Also Published As

Publication number Publication date
WO2022203044A1 (ja) 2022-09-29
US20240175098A1 (en) 2024-05-30
EP4317460A1 (en) 2024-02-07
EP4317460A4 (en) 2024-10-23
EP4317460B1 (en) 2025-12-31
JP7612001B2 (ja) 2025-01-10

Similar Documents

Publication Publication Date Title
JPWO2022203044A1 (https=)
BR202021013683U2 (https=)
CN305698627S (https=)
CN305527887S (https=)
CN305635905S (https=)
CN305535083S (https=)
CN305534513S (https=)
CN305531605S (https=)
CN305530532S (https=)
CN305528049S (https=)
CN305527153S (https=)
CN305695801S (https=)
CN305695992S (https=)
CN305740340S (https=)
CN305738962S (https=)
CN305738469S (https=)
CN305737764S (https=)
CN305736596S (https=)
CN305724719S (https=)
CN305724690S (https=)
CN305723923S (https=)
CN305723088S (https=)
CN305722632S (https=)
CN305710627S (https=)
CN305535876S (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230905

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240802

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240926

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241224

R150 Certificate of patent or registration of utility model

Ref document number: 7612001

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350